Big pharmas are like Pac Man, muchn on the lil guys with EXCELLENT research and patents. This lil guy "ARIA" did not sell out, they believe and stand by their research. A patent is a intangible object that defines a company structure and holds GREAT GREAT GREAT value, that value has clearly been diminished out of fear. A patent is a asset, that big pharmas seek from the lil guys for big big$$$, It would be hard for Aria to ignore a buyout price for $15 per share given their current circumstances. ARIA is a multi national company whose product is beyond U.S borders, rallying in other global markets such as the E.U. region.
USPTO Grants Ponatinib Patent No. 8,114,874 entitled, "Substituted Acetylenic Imidazo[1,2-B] Pyridazine Compounds as Kinase Inhibitors," -THATS JUST ONE of THEIR PATENTS!!!
Just a thought, could be wrong or right or left or straight ..DD
My ride has already began at $6nholding.
News 
Market Data 
Discover 
